Carr Thomas M, Sabri Saher S, Turba Ulku C, Park Auh-Whan, Saad Wael E A, Angle J Fritz, Matsumoto Alan H
Department of Radiology, University of Virginia Health Systems, Charlottesville, VA 22908, USA.
Tech Vasc Interv Radiol. 2010 Jun;13(2):134-45. doi: 10.1053/j.tvir.2010.02.008.
Atherosclerotic renal artery stenosis (ARAS) is the most common cause of renal artery stenosis in the adult population. ARAS may result in progressive renal impairment, renovascular hypertension, and/or cardiac disturbance syndromes. Because medical therapy does not affect the progressive nature of this disease process, more aggressive treatments are needed to definitively treat ARAS. When performed correctly, renal artery stenting has been shown to stabilize or improve renal function and/or renovascular hypertension in 65-70% of carefully selected patients with ARAS. Therefore, percutaneous renal artery stenting should be considered the primary treatment for patients with symptomatic ARAS.
动脉粥样硬化性肾动脉狭窄(ARAS)是成年人群中肾动脉狭窄最常见的病因。ARAS可能导致进行性肾功能损害、肾血管性高血压和/或心脏紊乱综合征。由于药物治疗不会影响该疾病进程的进展性,因此需要更积极的治疗来明确治疗ARAS。当操作正确时,肾动脉支架置入术已被证明可使65%-70%经过精心挑选的ARAS患者的肾功能和/或肾血管性高血压得以稳定或改善。因此,经皮肾动脉支架置入术应被视为有症状ARAS患者的主要治疗方法。